Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Data: ECO-4601 also effective against breast and prostate cancer
June 16th, 2005
Ecopia BioSciences, Inc., (EIA) announced new positive in vivo data demonstrating that ECO-4601, the company's lead compound under development in brain cancer, is also active against breast and prostate cancer. In recent preclinical tests, ECO-4601 was shown to considerably reduce tumor growth in nude mice animal models bearing human breast cancer cells (the MDA-MB-231 model) and human prostate cancer cells (the PC3 model). ECO-4601 has already demonstrated potential in the treatment of primary brain tumor, an indication for which the company is currently preparing an investigational new drug application for clinical testing. In...
Source: Women's Health Weekly (2005-06-16)
|
